JP2022523530A5 - - Google Patents

Info

Publication number
JP2022523530A5
JP2022523530A5 JP2021550218A JP2021550218A JP2022523530A5 JP 2022523530 A5 JP2022523530 A5 JP 2022523530A5 JP 2021550218 A JP2021550218 A JP 2021550218A JP 2021550218 A JP2021550218 A JP 2021550218A JP 2022523530 A5 JP2022523530 A5 JP 2022523530A5
Authority
JP
Japan
Application number
JP2021550218A
Other languages
Japanese (ja)
Other versions
JP2022523530A (ja
JPWO2020176738A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/020115 external-priority patent/WO2020176738A1/en
Publication of JP2022523530A publication Critical patent/JP2022523530A/ja
Publication of JP2022523530A5 publication Critical patent/JP2022523530A5/ja
Publication of JPWO2020176738A5 publication Critical patent/JPWO2020176738A5/ja
Abandoned legal-status Critical Current

Links

JP2021550218A 2019-02-28 2020-02-27 化膿性汗腺炎の治療のための抗IL-α抗体 Abandoned JP2022523530A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962811696P 2019-02-28 2019-02-28
US62/811,696 2019-02-28
PCT/US2020/020115 WO2020176738A1 (en) 2019-02-28 2020-02-27 Anti-il-alpha antibody for the treatment of hidradenitis suppurativa

Publications (3)

Publication Number Publication Date
JP2022523530A JP2022523530A (ja) 2022-04-25
JP2022523530A5 true JP2022523530A5 (https=) 2023-03-01
JPWO2020176738A5 JPWO2020176738A5 (https=) 2023-03-01

Family

ID=70110308

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021550218A Abandoned JP2022523530A (ja) 2019-02-28 2020-02-27 化膿性汗腺炎の治療のための抗IL-α抗体

Country Status (11)

Country Link
US (1) US20200277370A1 (https=)
EP (1) EP3930752A1 (https=)
JP (1) JP2022523530A (https=)
KR (1) KR20210134927A (https=)
CN (1) CN113905760A (https=)
AU (1) AU2020228299A1 (https=)
BR (1) BR112021016845A2 (https=)
CA (1) CA3131011A1 (https=)
MX (1) MX2021010402A (https=)
TW (1) TW202045537A (https=)
WO (1) WO2020176738A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102167261B1 (ko) 2010-06-18 2020-10-20 엑스바이오테크, 인크. 관절염 치료
CA3095740A1 (en) 2020-10-07 2022-04-07 Xbiotech Inc. True human antibody specific for interleukin alpha (il-1a)
CA3095675A1 (en) 2020-10-07 2022-04-07 Xbiotech Inc. True human antibody specific for interleukin 1 alpha (il-1a)
CA3095676A1 (en) * 2020-10-07 2022-04-07 Xbiotech Inc. True human antibody specific for interleukin 1 alpha (il-1a)
CA3095679A1 (en) 2020-10-07 2022-04-07 Xbiotech Inc. True human antibody specific for interleuken 1 alpha (il-1a)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2726345C (en) 2008-05-30 2018-08-28 John Simard Interleukin-1 alpha antibodies and methods of use
JP5812669B2 (ja) 2011-04-27 2015-11-17 キヤノン株式会社 画像処理装置および画像処理方法およびコンピュータプログラム。
ES2688821T3 (es) 2012-11-02 2018-11-07 Repros Therapeutics Inc. Métodos y composiciones para tratar afecciones dependientes de la progesterona
KR101753553B1 (ko) 2014-06-03 2017-07-03 엑스바이오테크, 인크. 스타필로코커스 아우레우스 감염의 치료 및 예방을 위한 조성물 및 방법
CA3053231A1 (en) * 2017-02-16 2018-08-23 Xbiotech Inc. Treatment of hidradenitis suppurativa

Similar Documents

Publication Publication Date Title
JPWO2023127375A1 (https=)
CN306651899S (https=)
CN305730049S (https=)
CN306128587S (https=)
CN306129776S (https=)
CN306130318S (https=)
CN306132777S (https=)
CN306134309S (https=)
CN306141022S (https=)
CN306157401S (https=)
CN306169279S (https=)
CN306176466S (https=)
CN306179510S (https=)
CN306182060S (https=)
CN306646263S (https=)
CN306646499S (https=)
CN306647355S (https=)
CN306649644S (https=)
CN306651582S (https=)
CN306757156S (https=)
CN306653595S (https=)
CN306655073S (https=)
CN306656146S (https=)
CN306657724S (https=)
CN306658327S (https=)